Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
2.060
+0.470 (29.56%)
At close: Jan 23, 2026, 4:00 PM EST
1.920
-0.140 (-6.80%)
After-hours: Jan 23, 2026, 7:59 PM EST
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $248.99 million as of January 23, 2026. Its market cap has increased by 37.64% in one year.
Market Cap
248.99M
Enterprise Value
111.65M
1-Year Change
37.64%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $248.99M, a decrease of -38.40%. That is a compound annual growth rate of -4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 249.00M | 45.10% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 268.76M |
| Shattuck Labs | 262.61M |
| Fennec Pharmaceuticals | 261.62M |
| Nautilus Biotechnology | 261.45M |
| Heron Therapeutics | 260.37M |
| Enlivex Therapeutics | 256.37M |
| Crescent Biopharma | 250.24M |
| Climb Bio | 239.68M |